Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 37 páginas
Examen

APEA Neuro Pharmacology | Latest 2025 Revised Questions & Correct Detailed Answers Verified

Document preview thumbnail
Vista previa 4 fuera de 37 páginas

Prepare with APEA – Neuro Pharmacology – Latest 2025 Revised Exam Questions and Correct Detailed Answers, authored by Physician Assistant Education Association (PAEA). This verified resource includes detailed rationales covering neurologic disorders, pharmacologic management, mechanisms of action, adverse effects, drug interactions, dosing guidelines, and clinical decision-making, helping PA students master neuropharmacology concepts and confidently succeed on APEA exams.

Vista previa del contenido

RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)1
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




APEA- NEURO PHARM LATEST 2025
REVISED EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS
(VERIFIED COMPLETE SOLUTION)
ALREADY PASSED SCORE A+



restless leg syndrome and Parkinson disease.
Pramipexole (Mirapex), a dopamine agonist, is indicated in the treatment of:
insomnia and parasomnia disorders.
Parkinson disease and sleep-related eating disorders.
REM sleep behavior disorder and multiple sclerosis.
restless leg syndrome and Parkinson disease.




a 43-year-old woman with hypothyroidism.
The patient who requires the LEAST cautionary measures when treated with
carbidopa/levodopa (Sinemet) is:
a 43-year-old woman with hypothyroidism.
a 45-year-old retired marine with secondary parkinsonism and a history of post-
traumatic stress disorder.



-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

,RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)2
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




a 50-year-old woman with a history of obstructive sleep apnea.
a 55-year-old man with history a of myocardial infarction with residual atrial
arrhythmia.




tardive dyskinesia.
Benztropine (Cogentin), an anticholinergic, is NOT recommended for use in
patients with:
athetosis movements.
Huntington's chorea.
parkinsonism.
tardive dyskinesia.




hepatic impairment.
A patient presenting with a transient ischemic attack (TIA) is taking nifedipine
(Adalat CC) for hypertension. Pharmacokinetics of nifedipine may be altered in
patients with:
renal insufficiency.
hepatic impairment.
irritable bowel disease.
G6PD deficiency.




-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

,RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)3
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




acetylsalicylic acid.
A medication used in a patient with a transient ischemic attack to prevent platelet
aggregation and produce an anti-inflammatory effect in vessels by inhibiting
prostaglandin synthesis is:
acetaminophen.
ibuprofen.
acetylsalicylic acid.
warfarin.




narrow-angle glaucoma.
Carbidopa/levodopa (Sinemet) for the treatment of Parkinson's disease is
contraindicated in patients with:
diabetes.
history of peptic ulcer disease.
narrow-angle glaucoma.
wide-angle glaucoma.




orthostatic hypotension.
During initiation of treatment and escalation of doses, pramipexole (Mirapex) and
other dopamine agonists are known to cause:
akathisia.



-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

,RM
HARM
LATEST
LATEST
Package
20252025
REVISED
Deal
REVISED
(2026/2027)4
EXAMEXAM
QUESTIONS
ofQUESTIONS
37 ANDAND
CORRECT
CORRECT
DETAILED
DETAILED
ANSWERS
ANSWERS
(VERIFIED
(VERIFIED
COMPLETE
COMPLETE
SOLUTION)
SOLUTION)
ALREADY
ALREADY
PASSED
PASSED
SCORE
SCORE
A+.pdf
A+Package




gastrointestinal bleeding.
orthostatic hypotension.
thrombocytopenia.




migraine headaches (acute).
Ergotamine alkaloids, such as dihydroergotamine (Migranal), are indicated in the
treatment of:
basilar migraine headaches.
cluster headaches.
migraine headaches (acute).
tension headaches.




ciprofloxacin (Cipro).
Patients who are taking rasagiline (Azilect) for the treatment of Parkinson's
disease should avoid other CYP1A2 inhibitors such as:
ciprofloxacin (Cipro).
clindamycin (Cleocin).
erythromycin base (Ery-Tab)
sulfamethoxazole/trimethoprim (Bactrim).




-EXAM
NEURO
QUESTIONS
Exam
PHARM
Q&A
LATEST
(2026/2027)
AND CORRECT
2025 REVISED
| Complete
DETAILED
EXAM
StudyANSWERS
QUESTIONS
Guide & Verified
(VERIFIED
ANDQuestions
CORRECT
COMPLETE
with
DETAILED
Correct
SOLUTION)
AnswersAPEA-
ANSWERS
ALREADY
(VERIFIED
NEURO
PASSED
PHARM
COMPLETE
SCORE
LATEST
A+.pdf=Package
SOLUTION)
2025 REVISED
ALREADY
DealEXAM
(2026/2027)
PASSED
QUESTIONS
SCOREA

Información del documento

Subido en
17 de enero de 2026
Número de páginas
37
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$21.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
UniTest
4.8
(220)
Vendido
8276
Seguidores
16
Artículos
776
Última venta
6 días hace


Reseñas de compradores verificados



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes